ELAN CP PLC ADR ELN (NYSE)

(NEW YORK)Shares of Myriad Genetics Inc. fell Monday morning after the company said it will end development of Alzheimer's disease drug candidate Flurizan, after it proved no better than...READ MORE

(NEW YORK)Shares of Irish drug maker Elan Corp. PLC hit a six-year high Monday as one analyst predicted success for its Alzheimer's disease treatment bapineuzumab, and another voiced ske...READ MORE

(NEW YORK)Shares of Elan Corp. PLC rose to their highest level in six years Tuesday after data showed a drug developed in part by the Irish biopharmaceuticals company had positive results wi...READ MORE

Among the stock activity stories for Tuesday, June 17, from AP Financial News: NEW YORK (AP)--Shares of CME Group Inc. and Nymex Holdings Inc. both rose sharply Tuesday, a day afte...READ MORE

(NEW YORK)NEW YORK (AP)--Shares of pharmaceutical companies closed mixed Tuesday as the broader market lost ground on Labor Department data showing its index of producer prices jumped 1.4 pe...READ MORE

(NEW YORK)Shares of Wyeth and Elan Corp. rose Tuesday as data showed their new Alzheimer's drug bapineuzumab helped a large subgroup of the patient population. In midday trading, Wyeth s...READ MORE

(MADISON, N.J.)Wyeth and Elan Corp. said Tuesday a mid-stage study for a drug to treat Alzheimer's disease did not meet its goal. According to the drug makers, bapineuzumab's ability to i...READ MORE